Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Ribbon Bio logo — Synthetic DNA Built without Bacteria. At your Lab Bench.

Ribbon Bio

Synthetic DNA Built without Bacteria. At your Lab Bench.

Founded 2018 Austria Austria 63 employees Series A Total: $18.00M Biotechnology

General Information

Company Name Ribbon Bio
Founded Year 2018
Location Austria Austria
Founders / Decision Makers
Team member
Employees 63
Industries Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Ribbon Bio. To contact Ribbon Bio, visit ribbonbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Ribbon Bio compare?

A PDF of Ribbon Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Ribbon Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Award Received Nov 05, 2026

Ribbon Bio's MiroMine™ was named DNA Synthesis Solution of the Year in the 2026 BioTech Breakthrough awards.

Product Launch Nov 05, 2026

Ribbon Bio launched MiroMine™, a cell-free DNA assembly kit that replaces traditional cloning methods.

Event Participation Nov 04, 2026

Ribbon Bio is participating as a guest speaker at the DISPENDIX User Group Meeting in London.

Major Customer Win Oct 29, 2026

Flock Bio successfully used Ribbon Bio's MiroMine™ in an Early Access Program to generate 12 DNA fragments.

Ribbon Bio a competitor of yours? Have our desk watch it

About Ribbon Bio

Ribbon Biolabs:

Ribbon Biolabs, a biotech start-up founded in 2018 and headquartered in Austria, is revolutionizing DNA synthesis with its innovative approach. The company aims to develop a cost-efficient platform for error-proof DNA synthesis, enabling the production of long and complex DNA molecules. This breakthrough technology has the potential to drive a new generation of biopharmaceutical processes and other synthetic biology products.

The company recently received a substantial €18.00M Series A investment on 31 January 2022 from a group of prominent investors including Tecnet Equity, Hadean Partners, Helicase Venture, Lansdowne Partners, and xista science ventures.

Ribbon Biolabs prides itself on its international and highly motivated team based in Vienna, constantly seeking new talents to propel the company to the next level. With its slogan "Give Life To Possibilities," Ribbon Biolabs is poised to make a significant impact in the biotechnology industry and beyond.

Business keywords: biotech, DNA synthesis, molecular biology, synthetic biology, biopharmaceutical, technology, start-up, innovation, Vienna, biotech industry, talent acquisition, error-proof DNA synthesis, cost-efficient platform, international team

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €18.00M 5
Tecnet Equity Hadean Partners Helicase Venture
Tecnet Equity, Hadean Partners +3
31 Jan 2022
Seed Round Undisclosed 2
Tecnet Equity xista science ventures
Tecnet Equity, xista science ventures
08 Mar 2019

Latest News

View All
Ribbon Bio’s MiroMine™ DNA Assembly Kit Named “DNA Synthesis Solution of the Year” In 2026 BioTech B... — Yahoo Finance
Ribbon Bio’s MiroMine™ DNA Assembly Kit Named “DNA Synthesis Solution of the Year” In 2026 BioTech Breakthrough Awards Program
Yahoo Finance Nov 05, 2026

Ribbon Bio Alternatives & Competitors

View All Alternatives
Ribbon Bio vs
Telesis Bio
Telesis Bio United States

Accelerating the path from AI-driven design to physical biology.

Post-IPO Equity
49 employees
Biotechnology, Health Care
Compare Ribbon Bio vs Telesis Bio
Ribbon Bio vs
Synbio Technologies
Synbio Technologies United States

Changing the world, one sequence at a time.

25 employees
Biotechnology, Health Care
Compare Ribbon Bio vs Synbio Technologies
Ribbon Bio vs
ELEGEN
ELEGEN United States

Unlock the promise of synthetic biology by accelerating the Design-Build-Test-Learn cycle

Series B
58 employees
Biotechnology, Health Care
Also compare with: Ribbon Bio vs Ansa Biotechnologies, Inc. Ansa Biotechnologies, Inc. Ribbon Bio vs Tsingke Biotech Tsingke Biotech Ribbon Bio vs DNA Script DNA Script View all alternatives

FAQ About Ribbon Bio

Synthetic DNA Built without Bacteria. At your Lab Bench.
Ribbon Bio was founded in 2018.
Ribbon Bio is headquartered in Austria.
Ribbon Bio operates in Biotechnology. Its work centres on biotech, DNA synthesis, molecular biology and synthetic biology.
Ribbon Bio has approximately 63 employees.
Ribbon Bio has completed 2 funding rounds, raising a total of $18.00M. The latest funding stage is Series A.
Top alternatives and competitors to Ribbon Bio include Telesis Bio, Synbio Technologies, ELEGEN, Ansa Biotechnologies, Inc., Loop Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ribbon Bio and Telesis Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Ribbon Bio, https://bouncewatch.com/company/ribbon-biolabs, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout